NEO•benzinga•
Piper Sandler Maintains Overweight on NeoGenomics, Lowers Price Target to $18
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 26, 2025 by benzinga